Skip to main content

Sentinel Node Biopsy Market Sales, End User Price Analysis, Revenue, Gross Margin and Market Share

The Sentinel Node Biopsy Market Global Industry Size Is Expected to Grow at a CAGR of 5.1% During the Forecast Period.
Improving economic conditions worldwide are defining the growth of the sentinel node biopsy market, enabling access to the quality of life & to the improved healthcare. Furthermore, factors such as increasing number of biopsy procedures and rising demand for new techniques for the diagnosis of cancerous growth provide significant impetus to the market growth.
Market Overview
The global sentinel node biopsy market is growing pervasively mainly due to the increasing prevalence of various types of cancer including melanoma, colon cancer, breast cancer, esophageal cancer, head and neck cancer among others.
Key Players Leading the Global Sentinel Node Biopsy Market Include –
Devicor Medical Products Inc. (Germany)
  1. R. Bard Inc. (U.S.)
Hilfe Engineering Corporation (India)
Intramedical Imaging LLC (U.S.)
KUB Technologies Inc. (U.S.)
Surgic Eye (Germany)
Navidea Biopharmaceuticals Inc. (U.S.)
and among others.
These key players invest heavily in developing the pipeline of innovative tests to address unmet patient needs.  They strive to develop non-invasive, comprehensive and proven effective, tests that can help to match advanced-cancer patients with the approved targeted therapies as well as drugs in clinical trials.
On the other hand, factors such as prohibitive costs associated with the biopsy and the large unmet need are some of the key factors impeding the market growth, especially in the developing nations.
By Product       : Breast Localization Wire, Tissue Marker, Gamma Probe, and Drainage Catheters among others.
By Indication:  Breast Cancer, Melanoma, Colon Cancer, and Esophageal Cancer among others.
By End-user     : Hospitals & Clinics, and Diagnostic Centers among others.
By Regions       : North America, Asia Pacific, Europe, and the Rest-of-the-World.
LIST OF TABLES
Table 1 Sentinel Node Biopsy Industry Synopsis, 2017-2023
Table 2 Global Sentinel Node Biopsy Market Estimates And Forecast, 2017-2023, (USD Million)
Table 3 Global Sentinel Node Biopsy Market By Region, 2017-2023, (USD Million)
Table 4 Global Sentinel Node Biopsy Market By Products, 2017-2023, (USD Million)
Table 5 Global Sentinel Node Biopsy Market By Indication, 2017-2023, (USD Million)
Table 7 Global Sentinel Node Biopsy Market By End Users, 2017-2023, (USD Million)
Table 8 North America Sentinel Node Biopsy Market By Products, 2017-2023, (USD Million)
Table 9 North America Sentinel Node Biopsy Market By Indication, 2017-2023, (USD Million)
Table 11 North America Sentinel Node Biopsy Market By End Users, 2017-2023, (USD Million)
Continued.
Industry/Innovations/Related News:
  • January 30, 2019 —- Castle Biosciences, Inc. (the US), a skin cancer diagnostics company providing personalized genomic information to improve cancer management decisions, published the clinical test result of its Melanoma test – the DecisionDx ® – useful to determine decisions for the use of sentinel lymph node biopsy, a surgical procedure used to help stage melanoma.
  • The data supporting the clinical use of the DecisionDx indicates that the test result can be used with clinicopathologic factors to inform patient recommendations for sentinel lymph node biopsy (SLNB) in line with national melanoma clinical practice guidelines.
Contact:
Market Research Future
+1 646 845 9312
Labels:

Comments

Post a Comment

Popular posts from this blog

Hemifacial Spasm Market Application Scope, Types, Technology Benefits and Global Business

  Hemifacial Spasm Market  Research Information: By Diagnosis (Mri, Ct Or Cat Scan, Angiography (Arteriography)), Treatment (Medical Treatment, Surgical Treatment, Combinational Therapy, Tens, Physical Therapy, Others), End User – Global Forecast Till 2023 Market Highlights: Hemifacial spasm is a condition that causes frequent muscle spasms, on one side of the face. The condition can affect both men and women, but it is most prevalent in middle-aged or older women. Its incidence rate is also found to be higher among the Asian population. A number of factors such as increasing technological advancements, rising public awareness, increased incidence of craniofacial tremor, and facial chorea, unmet medical needs, increasing government assistance, improving regulatory framework, increasing adoption rate, and improvement in funding and reimbursement policies are propelling the growth of the global hemifacial spasm market. However, difficult diagnosis, cost of treatment, side-effect...
Post a Comment
Read more

U.S. Uterine Fibroid Market Latest Devices, Key Players Statistics Data, Regional Business Outlook 2022

U.S. Uterine Fibroid Market by Type (Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others), by Diagnosis (Medical Resonance Imaging (MRI) scanners, Computed Tomography (CT), Ultrasounds and others) and Treatment (Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy) - Forecast to 2022 The  US Uterine Fibroid Market  report offers insights into the leading market players and presents an assessment of their current market position. Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives is also available in the report Major Key Players To gain a substantially large competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch. These are the Top Market...
Post a Comment
Read more

Global Merkel Cell Carcinoma Market Clincial Assessment and Professional Industry Outlook 2023

  Global Merkel Cell Carcinoma Market  Research Report: By Diagnosis (Physical Examination, Sentinel Node Biopsy, Imaging Test), Treatment (Surgery, Radiation Therapy, Chemotherapy), End User (Hospitals & Clinics, Diagnostic Centers) – Forecast till 2023 Market Highlights Increasing prevalence of Merkel cell carcinoma and growing geriatric population are estimated to be the major drivers for the market growth during the forecast period. Moreover, increasing R&D expenses by the key market players, rising mortality rate by MCC, and growing healthcare expenditure is further boosting the market growth. However, the high cost of therapeutics and related side effects along with the lack of awareness and low per capita healthcare expenditures in the developing economies restrains the market growth.  Intended Audience Pharmaceutical Companies Biotechnological Institutes Government and Private Laboratories Research and Development (R&D) Companies Medical Research Labor...
Post a Comment
Read more